LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA), CAS [[2828433-17-4]]

Product Overview

• Article Name: LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA), CAS [[2828433-17-4]]
• Biozol Catalog Number: MCE-HY-P0299A
• Supplier Catalog Number: HY-P0299A
• Alternative Catalog Number: MCE-HY-P0299A-10MG,MCE-HY-P0299A-25MG,MCE-HY-P0299A-5MG
• Manufacturer: MedchemExpress
• Category: Proteine/Peptide

Product Description

LSKL, Inhibitor of Thrombospondin (TSP-1) TFA is a latency-associated protein (LAP)-TGFbeta derived tetrapeptide and a competitive TGF-beta1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-beta1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) TFA can readily crosse the blood-brain barrier[1][2].

Product Properties

• Molecular Weight: 458.60 (free base)
• Purity: 99.51
• CAS Number: [2828433-17-4]
• Formula: C21H42N6O5xC2HF3O2
• Target: TGF-beta Receptor

Application Notes

• Application Notes: MCE Product type: Peptides